UBS Group’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.1M Buy
377,237
+163,849
+77% +$14.5M 0.01% 1998
2025
Q4
$17.1M Buy
213,388
+86,065
+68% +$7.21M ﹤0.01% 2729
2025
Q3
$12.4M Sell
127,323
-70,694
-36% -$5.69M ﹤0.01% 3060
2025
Q2
$13.8M Sell
198,017
-74,121
-27% -$4.23M ﹤0.01% 2772
2025
Q1
$13.5M Buy
272,138
+23,748
+10% +$1.5M ﹤0.01% 2749
2024
Q4
$17.4M Buy
248,390
+112,646
+83% +$9.36M ﹤0.01% 2479
2024
Q3
$14.2M Sell
135,744
-23,742
-15% -$2.78M ﹤0.01% 2087
2024
Q2
$22.7M Sell
159,486
-36,581
-19% -$4.22M 0.01% 1586
2024
Q1
$21.9M Sell
196,067
-21,692
-10% -$2.58M 0.01% 1618
2023
Q4
$28.2M Buy
217,759
+53,838
+33% +$7.42M 0.01% 1349
2023
Q3
$26.7M Buy
163,921
+38,234
+30% +$6.72M 0.01% 1271
2023
Q2
$23M Sell
125,687
-34,794
-22% -$5.01M 0.01% 1341
2023
Q1
$21.4M Buy
160,481
+1,384
+0.9% +$163K 0.01% 1343
2022
Q4
$12.6M Sell
159,097
-2,073
-1% -$146K ﹤0.01% 1747
2022
Q3
$9.76M Buy
161,170
+36,777
+30% +$2.38M ﹤0.01% 1811
2022
Q2
$6.82M Sell
124,393
-4,456
-3% -$258K ﹤0.01% 2111
2022
Q1
$9.73M Sell
128,849
-7,298
-5% -$499K ﹤0.01% 1960
2021
Q4
$10.2M Buy
136,147
+15,011
+12% +$889K ﹤0.01% 2125
2021
Q3
$5.7M Sell
121,136
-7,989
-6% -$348K ﹤0.01% 2528
2021
Q2
$5.22M Sell
129,125
-5,002
-4% -$207K ﹤0.01% 2632
2021
Q1
$5.51M Sell
134,127
-10,941
-8% -$408K ﹤0.01% 2490
2020
Q4
$4.22M Sell
145,068
-7,408
-5% -$192K ﹤0.01% 2628
2020
Q3
$3.35M Sell
152,476
-3,120
-2% -$79.6K ﹤0.01% 2566
2020
Q2
$4.33M Sell
155,596
-78,682
-34% -$1.92M ﹤0.01% 2148
2020
Q1
$4.29M Sell
234,278
-25,604
-10% -$595K ﹤0.01% 2060
2019
Q4
$6.26M Buy
259,882
+17,751
+7% +$374K ﹤0.01% 2395
2019
Q3
$4.14M Buy
242,131
+20,978
+9% +$335K ﹤0.01% 2568
2019
Q2
$3.33M Buy
221,153
+7,064
+3% +$126K ﹤0.01% 2679
2019
Q1
$4.31M Buy
214,089
+3,879
+2% +$78.8K ﹤0.01% 2325
2018
Q4
$3.74M Sell
210,210
-11,894
-5% -$211K ﹤0.01% 2445
2018
Q3
$4.36M Buy
222,104
+2,140
+1% +$44.1K ﹤0.01% 2477
2018
Q2
$4.36M Buy
219,964
+4,703
+2% +$103K ﹤0.01% 2457
2018
Q1
$5.29M Sell
215,261
-6,704
-3% -$176K ﹤0.01% 2249
2017
Q4
$6.37M Sell
221,965
-4,514
-2% -$142K ﹤0.01% 2113
2017
Q3
$6.19M Sell
226,479
-6,307
-3% -$140K ﹤0.01% 2013
2017
Q2
$4.88M Buy
232,786
+2,483
+1% +$52.5K ﹤0.01% 2164
2017
Q1
$4.33M Buy
230,303
+2,827
+1% +$44.5K ﹤0.01% 2205
2016
Q4
$3.31M Buy
227,476
+19,815
+10% +$270K ﹤0.01% 2445
2016
Q3
$2.76M Sell
207,661
-1,382
-0.7% -$16K ﹤0.01% 2555
2016
Q2
$2.25M Sell
209,043
-6,481
-3% -$69.5K ﹤0.01% 2678
2016
Q1
$2.41M Buy
215,524
+30,136
+16% +$308K ﹤0.01% 2508
2015
Q4
$1.92M Buy
185,388
+4,916
+3% +$52.2K ﹤0.01% 2828
2015
Q3
$1.93M Buy
180,472
+4,054
+2% +$49.4K ﹤0.01% 2777
2015
Q2
$2.09M Sell
176,418
-8,375
-5% -$97K ﹤0.01% 2934
2015
Q1
$1.76M Buy
184,793
+44,090
+31% +$456K ﹤0.01% 3052
2014
Q4
$1.44M Buy
+140,703
New +$1.22M ﹤0.01% 3233

Other funds holding ACLS

UBS Group's ACLS Position: Q1 2026 in Review

UBS Group increased its Axcelis (ACLS) stake by 77% in Q1 2026, buying an estimated $14.5M and bringing the position to 377,237 shares worth $35.1M. The position accounts for 0.01% of the portfolio, ranked #1998.

UBS Group first reported a position in ACLS in Q4 2014 and has held it in 46 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • UBS Group held 377,237 shares of Axcelis worth $35.1M as of Q1 2026.
  • UBS Group bought 163,849 Axcelis shares in Q1 2026, an estimated $14.5M.
  • Axcelis made up 0.01% of UBS Group's portfolio in Q1 2026, its #1998 holding.
  • UBS Group first reported a position in Axcelis in Q4 2014 and has held it in 46 quarters since.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.